v3.26.1
Investments In Affiliated Companies, Partnerships And Other Companies (Tables)
 12 Months Ended
Dec. 31, 2025
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Abstract]  
Investments In Affiliated Companies
 December 31, 2025December 31, 2024
Companies accounted for under the equity method(1)
$113,339 $101,145 
Companies accounted for under the fair value method and other investments(2)
13,561 24,862 
 $126,900 $126,007 

(1)    See Note 6B.
(2)    See Note 6C.
Schedule of investments in companies accounted for under the equity method
 December 31, 2025December 31, 2024
Company A (1)
$99,102 $88,974 
Company B (2)
5,634 5,220 
Company C (3)
4,147 3,641 
Other 4,456 3,310 
 $113,339 $101,145 
Schedule Of Equity In Net Earnings Of Affiliated Companies
Equity in net earnings of affiliated companies and partnerships is as follows:
Year ended December 31, 2025Year ended December 31, 2024Year ended December 31, 2023
Company A$25,556 $20,492 $10,526 
Company B
1,088 1,582 1,822 
Company C
506 522 (93)
Other
2,093 (3,420)20 
 $29,243 $19,176 $12,275 
Balance Sheet Information
The summarized aggregate financial information of companies accounted for under the equity method is as follows:

Balance Sheet Information:
December 31, 2025December 31, 2024
Current assets$368,866 $327,961 
Non-current assets147,926 159,219 
Total assets$516,792 $487,180 
Current liabilities$253,886 $229,280 
Non-current liabilities59,468 66,165 
Shareholders' equity203,438 191,735 
Total liabilities and equity$516,792 $487,180 
Income Statement Information
Income Statement Information:
Year ended December 31, 2025Year ended December 31, 2024Year ended December 31, 2023
Revenues$455,127 $390,225 $328,138 
Gross profit$161,142 $143,055 $111,698 
Net income$52,792 $32,440 $10,391 
Investments accounted for under the fair value method
Investments accounted for under the fair value method are evaluated by applying relevant methods as the market approach with the use of an option pricing method or the earning approach using discounted future cash flows, as follows:
 December 31, 2025December 31, 2024
Company D (1)
$13,561 $13,561 
Company E (2)
— 7,301 
Company F (3)
— 4,000 
$13,561 $24,862 
(1)    Company D is an Israeli Company held 5% by the Company. During 2025 and 2024 there was no indication of change in Company D fair value.

(2)    Company E engages in developing surgeon-centered visualization technologies. During 2021, following a third party investments, the Company re-evaluated the fair value of its holdings in Company E and recognized in other income a gain of approximately $4,800. During 2022, the Company invested in Company E $1,400 and following third parties investments, the Company re-evaluated the fair value of its holdings in Company E and recognized in other income a gain of approximately $3,200. During 2023, the Company invested in Company E $3,600 and following third parties investments, the Company re-evaluated the fair value of its holdings in Company E and recognized in other income a loss of approximately $1,300. During 2024 the Company invested in Company E $2,800. The Company re-evaluated the fair value of its holding in Company E and during 2025 and 2024 the Company recognized in other income a loss of approximately$7,300 and $14,900, respectively (See Note 26).

(3) Company F is an Israeli company of which the Company owns 25% of the outstanding share capital, which is engaged in the field of tactical ground robotic systems. During the first quarter of 2022 the Company invested $2,000 in Company F. During the last quarter of 2022 the Company re-evaluated its investment in Company F and decreased its value in the amount of approximately $4,000. During 2024 there was no indication of change in Company F fair value. During 2025, the Company sold its holdings in Company F for the proceeds of approximately $16,000, as a result the company recognized a gain of approximately $12,000 (see Note 26).